Top Markets
#1 Siacoin Siacoin +33.47%
#2 The Bitcoin Bull The Bitcoin Bull +28.52%
#3 DogBull DogBull +26.50%
#4 Merlin's Seal BTC Merlin's Seal BTC +25.80%
#5 Cash Cat Cash Cat +21.33%
#6 Pons Pons +17.31%
#7 MarsCoin MarsCoin +12.84%
#8 Cryptopia Cryptopia +10.93%
#9 0G 0G +10.17%
#10 Useless Coin Useless Coin +7.81%
Coin of the day
Siacoin Siacoin
Settings
Language
ENGLISH
Currency
USD
Theme
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc.

FENC
Rank in Stocks #14216
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading... Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Share Price
$12.33
Last synced: 2026-08-31
Market Cap
$428.31M
Change (1 day)
0.49%
Change (1 year)
39.01%
Country
US
Trade Fennec Pharmaceuticals Inc. (FENC)

Category

Healthcare
Earnings for Fennec Pharmaceuticals Inc. (FENC)
Earnings in 2026 TTM: 0
According to Fennec Pharmaceuticals Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Fennec Pharmaceuticals Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH